Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues

Circulation
Z WangS Nattel

Abstract

Flecainide and other class IC antiarrhythmic drugs are effective in the prevention and termination of atrial fibrillation, but the mechanism of this action is unknown. To gain insights into potential cellular mechanisms, we evaluated the response of human atrial action potentials to equimolar therapeutic concentrations of flecainide and quinidine and compared this response to that of guinea pig, rabbit, and dog atria. Both compounds reduced Vmax more as activation rate increased, but flecainide was more potent than quinidine and had slower kinetics. The rate-dependence of Vmax reduction was similar for all species, but human tissue was more sensitive to the drugs tested. In contrast to changes in Vmax, drug-induced alterations in action potential duration showed opposite rate-dependence for the two drugs. Quinidine increased action potential duration to 95% repolarization (APD95) in human atria by 33 +/- 7% (mean +/- SD) at a cycle length of 1,000 msec, but this effect was reduced as cycle length decreased, to 12 +/- 4% (p less than 0.001) at a cycle length of 300 msec. Flecainide increased APD95 (by 6 +/- 3%) much less than quinidine at a cycle length of 1,000 msec, but its effect was increased by faster pacing, to 27 +/- 12% ...Continue Reading

References

Mar 1, 1990·Cardiovascular Research·B Le GrandL Guize
Apr 1, 1989·Journal of the American College of Cardiology·S NattelM Talajic
Sep 1, 1988·Progress in Cardiovascular Diseases·W M JackmanR Lazzara
Jun 1, 1987·The American Journal of Cardiology·E BernsG V Naccarelli
Aug 25, 1988·The American Journal of Cardiology·F Chouty, P Coumel
Aug 25, 1988·The American Journal of Cardiology·J J GoyU Sigwart
Sep 1, 1986·The American Journal of Cardiology·A BorgeatU Sigwart
Feb 1, 1985·Journal of the American College of Cardiology·N IkedaO Hauswirth
Jan 1, 1985·European Journal of Clinical Pharmacology·J J GoyU Sigwart
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
Jan 1, 1984·Journal of Cardiovascular Pharmacology·S NattelB I Sasyniuk
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·L M Hondeghem, B G Katzung
Nov 1, 1980·Journal of Molecular and Cellular Cardiology·K R Courtney
Nov 1, 1981·The American Journal of Cardiology·R G Samuelsson, D C Harrison
Jul 1, 1983·Journal of the American College of Cardiology·J L AndersonS B Allison
Jan 1, 1980·Progress in Biophysics and Molecular Biology·M R Boyett, B R Jewell
Feb 1, 1964·American Heart Journal·G K MOEJ A ABILDSKOV

❮ Previous
Next ❯

Citations

Oct 1, 1996·Clinical Cardiology·M Reardon, A J Camm
Jul 23, 2011·Pflügers Archiv : European journal of physiology·Claire A MartinChristopher L-H Huang
Jun 1, 1991·Journal of the American College of Cardiology·M E WechslerE G Giardina
Jul 1, 1993·Journal of the American College of Cardiology·R CappatoG E Antonioli
Nov 24, 1999·The American Journal of Cardiology·B N Singh
Nov 24, 1999·The American Journal of Cardiology·B N SinghJ S Sarma
Feb 11, 1999·Journal of the American College of Cardiology·G BorianiB Magnani
Jun 29, 2001·Trends in Cardiovascular Medicine·S SabaN A Estes
May 18, 1999·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·N FujishiroH Kawata
Apr 16, 1999·British Journal of Pharmacology·A SekiH Kasanuki
Jan 1, 1998·The New England Journal of Medicine·A A Grace, A J Camm
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ricardo CaballeroEva Delpón
Dec 22, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jiun TuanG André Ng
Dec 9, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Etienne AliotJuan Tamargo
Jan 1, 1993·Fundamental & Clinical Pharmacology·C Funck-Brentano
Nov 1, 1992·Pacing and Clinical Electrophysiology : PACE·H V Huikuri, S Yli-Mäyry
Sep 1, 1995·Pacing and Clinical Electrophysiology : PACE·D W WhalleyA O Grant
Jul 6, 2000·Pacing and Clinical Electrophysiology : PACE·T OsakaI Kodama
Nov 1, 1994·Journal of Cardiovascular Electrophysiology·R H Falk, R I Fogel
Aug 1, 1994·Journal of Cardiovascular Electrophysiology·L M Hondeghem
Apr 1, 1997·Journal of Cardiovascular Electrophysiology·S NattelM Talajic
Sep 3, 2011·Science Translational Medicine·Jonathan D MorenoColleen E Clancy
Dec 14, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Thomas O'Hara, Yoram Rudy
Aug 14, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Byron N RobertsColleen E Clancy
Jun 14, 2012·Journal of Pharmacological and Toxicological Methods·Sonia GoineauGuillaume Froget
Dec 22, 2004·Journal of Cardiovascular Electrophysiology·Philippe Maury, Marc Zimmermann
Aug 13, 2004·European Journal of Pharmacology·Pascale GluaisMonique Adamantidis
Jul 1, 1992·Current Problems in Cardiology·D E Haines, J P DiMarco
Apr 11, 1992·American Heart Journal·A O Grant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.